dockets
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
103 rows where agency_id = "FDA" and docket_type = "Rulemaking" sorted by last_modified descending
This data as json, CSV (advanced)
Suggested facets: last_modified (date)
| id | agency_id | title | docket_type | last_modified ▲ | object_id |
|---|---|---|---|---|---|
| FDA_FRDOC_0001 | FDA | Recently Posted FDA Rules and Notices. | Rulemaking | 2026-05-15T12:06:13Z | 0b0000648039ac3c |
| FDA-2015-N-3469 | FDA | Bulk Drug Substances That Can Be Used To Compound Drug Products in Accordance With Section 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket | Rulemaking | 2026-05-14T19:23:47Z | 0b00006481ca7da5 |
| FDA-1995-S-0036 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 | Rulemaking | 2026-05-13T13:49:22Z | 0b0000648055af86 |
| FDA-2008-N-0152 | FDA | Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Technical Amendment | Rulemaking | 2026-05-12T13:46:22Z | 0b000064803e6ecb |
| FDA-2026-N-4659 | FDA | Medical Devices; Obstetrical and Gynecological Devices; Classification of the External Condom for Anal Intercourse or Vaginal Intercourse | Rulemaking | 2026-05-08T13:09:33Z | 0b000064b92b25ae |
| FDA-2026-N-4645 | FDA | Medical Devices; Ophthalmic Devices; Classification of the Corneal Storage Medium With Preservatives Including Antifungals | Rulemaking | 2026-05-06T13:43:01Z | 0b000064b92ad87b |
| FDA-2026-N-4644 | FDA | Medical Devices; Immunology and Microbiology Devices; Classification of the Device to Preserve and Stabilize Relative Abundances of Microbial Nucleic Acids in Clinical Samples | Rulemaking | 2026-05-06T13:36:42Z | 0b000064b92ad877 |
| FDA-2026-N-4643 | FDA | Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device | Rulemaking | 2026-05-06T13:30:07Z | 0b000064b92ac835 |
| FDA-1996-N-0006 | FDA | Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System | Rulemaking | 2026-05-01T14:17:00Z | 0b000064804f9917 |
| FDA-2026-N-4269 | FDA | Medical Devices; Neurological Devices; Classification of the Brain Temperature Measurement System | Rulemaking | 2026-04-30T13:34:43Z | 0b000064b928c56c |
| FDA-2026-N-4270 | FDA | Medical Devices; Radiology Devices; Classification of the Radiation Therapy Marking Device | Rulemaking | 2026-04-30T13:29:28Z | 0b000064b928af2b |
| FDA-2026-N-3946 | FDA | Medical Devices; Cardiovascular Devices; Classification of the Laser-Powered Inferior Vena Cava Filter Retrieval Catheter | Rulemaking | 2026-04-30T13:22:35Z | 0b000064b9267937 |
| FDA-2015-N-3534 | FDA | Bulk Drug Substances That Can Be Used To Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act | Rulemaking | 2026-04-29T18:15:45Z | 0b00006481cb06bd |
| FDA-2024-D-2977 | FDA | FDA Enforcement Policy for AAFCO-Defined Animal Feed Ingredients; Draft Guidance for Industry; Availability | Rulemaking | 2026-04-24T20:30:07Z | 0b000064865c5781 |
| FDA-2026-N-3930 | FDA | Medical Devices; Immunology and Microbiology Devices; Classification of the Alzheimer’s Disease Pathology Assessment Test | Rulemaking | 2026-04-22T12:42:49Z | 0b000064b9265131 |
| FDA-2026-N-3928 | FDA | Medical Devices; Ophthalmic Devices; Classification of the digital therapy device for amblyopia | Rulemaking | 2026-04-22T12:41:08Z | 0b000064b9265112 |
| FDA-2026-N-3929 | FDA | Medical Devices; Anesthesiology Devices; Classification of the Device for Sleep Apnea Testing Based on Mandibular Movement | Rulemaking | 2026-04-22T12:38:42Z | 0b000064b9265116 |
| FDA-2026-N-3900 | FDA | Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Setmelanotide Eligibility Gene Variant Detection System | Rulemaking | 2026-04-22T12:36:21Z | 0b000064b9264ffd |
| FDA-2014-N-0189 | FDA | Deeming Tobacco Products To Be Subject to the Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Regulations on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products | Rulemaking | 2026-04-20T14:55:36Z | 0b00006481554f10 |
| FDA-2026-N-2959 | FDA | Medical Devices; Ear, Nose, and Throat Devices; Classification of the Transcutaneous Electrical Nerve Stimulator for the Relief of Congestion | Rulemaking | 2026-04-16T13:22:49Z | 0b000064b922c445 |
| FDA-2026-N-2887 | FDA | Medical Devices; Orthopedic Devices; Classification of the Manual Surgical Instrument for Appropriate Patient Selection for Orthopedic Implant | Rulemaking | 2026-04-16T13:12:39Z | 0b000064b9225b28 |
| FDA-1995-N-0259 | FDA | Regulations Restricting the Sale & Distribution of Cigarettes & Smokeless Tobacco to Protect Children & Adolescents | Rulemaking | 2026-04-14T14:44:56Z | 0b00006480571c9d |
| FDA-2025-N-5996 | FDA | Medical Devices; Radiology Devices; Classification of Blood Irradiators | Rulemaking | 2026-04-09T14:39:48Z | 0b000064b9075db9 |
| FDA-2012-N-1210 | FDA | Food Labeling: Revision of the Nutrition and Supplement Facts Labels | Rulemaking | 2026-04-09T13:37:37Z | 0b00006481185d17 |
| FDA-2024-C-1085 | FDA | Phytolon Ltd; Filing of Color Additive Petition | Rulemaking | 2026-04-02T15:01:13Z | 0b00006486457d5c |
| FDA-2025-N-5995 | FDA | Effective Date of Requirement for Premarket Approval Applications for Blood Irradiators Intended to Prevent Metastasis | Rulemaking | 2026-03-26T16:49:40Z | 0b000064b9075b4e |
| FDA-2015-N-0101 | FDA | Safety and Effectiveness for Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Rulemaking | 2026-03-18T14:32:02Z | 0b000064819b0578 |
| FDA-2000-N-0108 | FDA | Safety Reporting Requirements Human Drug/Biological Products | Rulemaking | 2026-03-17T12:00:53Z | 0b000064804c262a |
| FDA-2015-N-1765 | FDA | General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products | Rulemaking | 2026-03-16T13:19:20Z | 0b00006481ae5abf |
| FDA-2024-N-2910 | FDA | Food Labeling: Front-of-Package Nutrition Information | Rulemaking | 2026-03-12T15:38:51Z | 0b000064865bd26a |
| FDA-2000-N-0044 | FDA | Labeling for Human Prescription Drug/Biologic Products | Rulemaking | 2026-03-06T18:10:25Z | 0b000064804aefdb |
| FDA-2021-N-1351 | FDA | Revising the National Drug Code Format and Drug Label Barcode Requirements | Rulemaking | 2026-03-05T14:56:05Z | 0b00006484ee7222 |
| FDA-2011-N-0179 | FDA | Information Required in Prior Notice of Imported Food | Rulemaking | 2026-02-25T13:54:39Z | 0b00006480c0d540 |
| FDA-2020-N-1383 | FDA | Revocation of Methods of Analysis Regulation | Rulemaking | 2026-02-23T17:57:31Z | 0b000064845eacc2 |
| FDA-2024-N-4016 | FDA | Revocation of Regulations Regarding the Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and The European Community | Rulemaking | 2026-02-23T17:56:00Z | 0b0000648665d84e |
| FDA-2015-N-0030 | FDA | Compounding of Human Drug Products Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket | Rulemaking | 2026-02-18T14:17:55Z | 0b000064819a3b34 |
| FDA-2008-P-0086 | FDA | Cheeses & Related Cheese Products; Proposal to Permit the Use of Ultrafiltered Milk; Extension of the Comment Period | Rulemaking | 2026-01-30T15:36:20Z | 0b000064803a81eb |
| FDA-2007-0629 | FDA | Cheeses & Related Cheese Products; Proposal to Permit the Use of Ultrafiltered Milk; Reopening of the Comment Period | Rulemaking | 2026-01-30T15:33:08Z | 0b000064803779c9 |
| FDA-2025-N-4622 | FDA | Immunology and Microbiology Devices; Reclassification of Nucleic Acid-Based Test Systems for Use with a Corresponding Approved Oncology Therapeutic Product | Rulemaking | 2026-01-28T17:58:22Z | 0b000064b8fedfa1 |
| FDA-2012-D-1002 | FDA | Questions and Answers Regarding Food Facility Registration | Rulemaking | 2026-01-27T18:17:19Z | 0b0000648111f41d |
| FDA-2000-N-0011 | FDA | Uniform Compliance Date for Food Labeling Regulations | Rulemaking | 2025-03-05T10:39:56Z | 0b000064804ae7d6 |
| FDA-1978-N-0018 | FDA | Sunscreen Drug Products -OPEN | Rulemaking | 2025-01-22T08:25:01Z | 0b00006480559264 |
| FDA-1975-N-0012 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED | Rulemaking | 2024-05-24T10:11:19Z | 0b000064805c1903 |
| FDA-2006-N-0239 | FDA | Index of Legally Marketed Unapproved New Animal Drugs for Minor Species | Rulemaking | 2024-05-15T09:29:00Z | 0b00006480456e9e |
| FDA-2003-F-0321 | FDA | Creamers for Use in Alcoholic Beverages | Rulemaking | 2023-10-13T14:23:03Z | 0b00006480495779 |
| FDA-1992-S-0039 | FDA | Public Docket to Provide Information on Submissions the Agency is Prepared to Accept Electronically | Rulemaking | 2023-07-21T16:50:48Z | 0b00006480528808 |
| FDA-2000-P-0126 | FDA | Revision of Yogurt Standards | Rulemaking | 2023-05-19T08:27:18Z | 0b000064804cf4c3 |
| FDA-1998-N-0051 | FDA | Over the Counter Human Drugs Labeling Requirements | Rulemaking | 2023-04-17T17:42:05Z | 0b0000648056e834 |
| FDA-2001-N-0178 | FDA | Performance Standard for Diagnostic X-Ray Systems and Their Major Components | Rulemaking | 2023-02-22T09:25:21Z | 0b000064804e14e6 |
| FDA-1997-N-0020 | FDA | Substances Generally Recognized as Safe (GRAS) - Closed | Rulemaking | 2022-01-05T01:02:36Z | 0b000064805ca0a0 |
| FDA-1975-N-0016 | FDA | OTC Topical Antimicrobial Drug Products - OPEN | Rulemaking | 2022-01-05T01:02:28Z | 0b000064805c1f98 |
| FDA-1975-N-0013 | FDA | First Aid; Topical Antimicrobial Drug Products for Over-the-Counter (OTC) Human Use (OPEN) | Rulemaking | 2022-01-05T01:02:27Z | 0b000064805c1d37 |
| FDA-1995-N-0063 | FDA | CGMPs for the Production of Infant Formula | Rulemaking | 2022-01-05T01:02:26Z | 0b0000648056ca61 |
| FDA-2003-N-0196 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients | Rulemaking | 2022-01-05T01:02:18Z | 0b0000648048b48b |
| FDA-2005-N-0345 | FDA | Distribution of Blood Derivatives by Registered Blood Establishments that Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures (Section 610 Review) | Rulemaking | 2022-01-05T01:02:18Z | 0b00006480449858 |
| FDA-2005-N-0404 | FDA | Food Labeling; Gluten-Free Labeling of Foods-CLOSED | Rulemaking | 2022-01-05T01:02:18Z | 0b0000648044d3d3 |
| FDA-1988-N-0019 | FDA | Prescription Drug Marketing Act of 1987 | Rulemaking | 2022-01-05T01:02:16Z | 0b00006480475d46 |
| FDA-1992-N-0407 | FDA | Prescription Drug Amendments of 1992; Ltr to Regulated Industy | Rulemaking | 2022-01-05T01:01:39Z | 0b00006480532581 |
| FDA-1977-N-0320 | FDA | Protein Supplements-RETIRED | Rulemaking | 2021-09-01T18:06:30Z | 0b000064805ee043 |
| FDA-1977-N-0259 | FDA | Cultured & Acidified Buttermilk, Yogurts, Milks & Eggnog - OPEN | Rulemaking | 2021-09-01T18:06:29Z | 0b000064805ed178 |
| FDA-1997-D-0494 | FDA | Direct Final Rule Procedures | Rulemaking | 2021-09-01T18:06:15Z | 0b000064805d46c6 |
| FDA-1980-N-0004 | FDA | Over-the-Counter Ophthalmic Drug Products for Emergency First Aid Use; Proposed Amendment of Final Monograph for Over-the-Counter Opthalmic Drug Products | Rulemaking | 2021-09-01T18:05:33Z | 0b000064805b9002 |
| FDA-1985-C-0553 | FDA | Canthaxanthin; Color Additive Exemtp From Ccertification | Rulemaking | 2021-09-01T18:05:32Z | 0b000064805b7c5a |
| FDA-1981-N-0293 | FDA | Standards of Identity for Milk, Lowfat Milk & Skim Milk Pasteurized | Rulemaking | 2021-09-01T18:05:12Z | 0b000064805b0e91 |
| FDA-1981-N-0114 | FDA | Topical Acne Drug Product For Over-the-Counter Human Use | Rulemaking | 2021-09-01T18:05:07Z | 0b000064805b0529 |
| FDA-1978-N-1975 | FDA | Red Cell Lysing Reagents -RETIRED | Rulemaking | 2021-09-01T18:04:31Z | 0b000064805a1aa4 |
| FDA-1978-N-1713 | FDA | Blood & Plasma Warming Devices-RETIRED | Rulemaking | 2021-09-01T18:04:17Z | 0b0000648059cab9 |
| FDA-1978-N-1451 | FDA | Blood Cell Diluents-RETIRED | Rulemaking | 2021-09-01T18:04:04Z | 0b0000648059b436 |
| FDA-1978-N-1463 | FDA | Processing Systems for Frozen Blood-RETIRED | Rulemaking | 2021-09-01T18:04:04Z | 0b0000648059b4f7 |
| FDA-1978-N-1177 | FDA | Calibrators for Platelet Counting-RETIRED | Rulemaking | 2021-09-01T18:03:42Z | 0b000064805984f6 |
| FDA-1978-N-0924 | FDA | Thrombin Time Test-RETIRED | Rulemaking | 2021-09-01T18:03:29Z | 0b0000648058dadc |
| FDA-1978-N-0925 | FDA | Calibrators for Cell Indices-RETIRED | Rulemaking | 2021-09-01T18:03:29Z | 0b0000648058dbd3 |
| FDA-1998-N-0155 | FDA | Treatment of Narcotic Dependence | Rulemaking | 2021-09-01T18:03:27Z | 0b0000648058b15e |
| FDA-1978-N-0635 | FDA | Empty Containers for the Collection & Processing of Blood-RETIRED | Rulemaking | 2021-09-01T18:03:18Z | 0b00006480579244 |
| FDA-1978-N-0622 | FDA | Calibrators for Red Cell & White Cell Counting | Rulemaking | 2021-09-01T18:03:17Z | 0b00006480578721 |
| FDA-1978-N-0624 | FDA | Medical Devices Classification of Prothrombin-Proconvertin Tests and Thrombotests-RETIRED | Rulemaking | 2021-09-01T18:03:17Z | 0b0000648057895b |
| FDA-1978-N-0625 | FDA | Partial Thromboplastin Time Tests-RETIRED | Rulemaking | 2021-09-01T18:03:17Z | 0b00006480578a8f |
| FDA-1978-N-0632 | FDA | Thromboplastin Generation Test-RETIRED | Rulemaking | 2021-09-01T18:03:17Z | 0b00006480579019 |
| FDA-1978-N-0633 | FDA | Automated Blood Grouping & Antibody Test Systems-RETIRED | Rulemaking | 2021-09-01T18:03:17Z | 0b00006480579087 |
| FDA-1978-N-0375 | FDA | Medical Devices Classification of Prothrombin Time Tests-RETIRED | Rulemaking | 2021-09-01T18:03:06Z | 0b0000648056e729 |
| FDA-1978-N-0379 | FDA | Classification of Blood Mixing Devices & Blood Weighing Devices-RETIRED | Rulemaking | 2021-09-01T18:03:06Z | 0b0000648056e7dd |
| FDA-1978-N-0380 | FDA | Automated Blood Cell Separators-RETIRED | Rulemaking | 2021-09-01T18:03:06Z | 0b0000648056e7f7 |
| FDA-1978-N-0381 | FDA | Automated Cell Washing Centrifuges for Immuno-Hematology-RETIRED | Rulemaking | 2021-09-01T18:03:06Z | 0b0000648056e829 |
| FDA-1978-N-0382 | FDA | Automated Coombs Test Systems-RETIRED | Rulemaking | 2021-09-01T18:03:06Z | 0b0000648056e83b |
| FDA-1978-N-0368 | FDA | Hematology Stains-RETIRED | Rulemaking | 2021-09-01T18:03:05Z | 0b0000648056e64a |
| FDA-1978-N-0123 | FDA | Hematology Quality Control Mixtures | Rulemaking | 2021-09-01T18:02:55Z | 0b00006480564674 |
| FDA-1978-N-0124 | FDA | Russell Viper Venom Reagent - RETIRED | Rulemaking | 2021-09-01T18:02:55Z | 0b00006480564725 |
| FDA-1978-N-0115 | FDA | Calibrators for Hemoglobin & Hematocrit Measurement-RETIRED | Rulemaking | 2021-09-01T18:02:54Z | 0b00006480564113 |
| FDA-1978-N-0061 | FDA | Hematology and Pathology Devices Classification of Sickle Cell Tests-RETIRED | Rulemaking | 2021-09-01T18:02:53Z | 0b000064805622ba |
| FDA-1978-N-0023 | FDA | Skin Bleaching Drug Products- OPEN | Rulemaking | 2021-09-01T18:02:51Z | 0b0000648055ed99 |
| FDA-1995-G-0034 | FDA | Hydrophobic Silica for Animal Feeds-CLOSED | Rulemaking | 2021-09-01T18:02:51Z | 0b0000648055add9 |
| FDA-1979-N-0424 | FDA | Labels of Drug & Cosmetic Products-RETIRED | Rulemaking | 2021-09-01T18:02:48Z | 0b0000648055648a |
| FDA-1979-N-0028 | FDA | Lakes of Color Additives | Rulemaking | 2021-09-01T18:02:36Z | 0b0000648055395f |
| FDA-1992-N-0190 | FDA | Standard Identity for Cheese Product FD&C Yellow No. 6 & 5 | Rulemaking | 2021-09-01T18:02:09Z | 0b0000648052f609 |
| FDA-1992-N-0049 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling | Rulemaking | 2021-09-01T18:01:56Z | 0b0000648052bcdf |
| FDA-1990-N-0025 | FDA | Food Labeling, Declaration of Ingredients | Rulemaking | 2021-09-01T18:01:53Z | 0b0000648052957f |
| FDA-1982-F-0155 | FDA | Direct Food Additives: Food Additives Permitted for Direct Addition to Food for Human Consuption; Dimethyl Dicarbonate | Rulemaking | 2021-09-01T18:01:19Z | 0b0000648050f5f7 |
| FDA-1996-N-0027 | FDA | National Environmental Policy Act Proposed Revision of Policies and Procedures | Rulemaking | 2021-09-01T18:00:26Z | 0b000064804fb548 |
| FDA-2002-N-0323 | FDA | Bioterrorism Preparedness; Registration of Food Facilities | Rulemaking | 2021-09-01T01:03:15Z | 0b000064804a02e5 |
| FDA-2002-N-0031 | FDA | Animal Proteins Prohibited in Ruminant Feed | Rulemaking | 2021-09-01T01:02:59Z | 0b00006480489512 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE dockets (
id TEXT PRIMARY KEY,
agency_id TEXT,
title TEXT,
docket_type TEXT,
last_modified TEXT,
object_id TEXT
);
CREATE INDEX idx_dockets_agency ON dockets(agency_id);
CREATE INDEX idx_dockets_type ON dockets(docket_type);